FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/ β-catenin signaling pathway-Reference-Cited by-同舟云学术

FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/ β-catenin signaling pathway

Published:2019-05 Issue: Volume:163 Page:234-249
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Xu Bingtian,Wang Tiantian,Xiao Jiao,Dong Wenli,Wen Hui-zhen,Wang Xinyi,Qin Yunyun,Cai Ningbo,Zhou Zhongzhen,Xu Jiangping,Wang Haitao

Funder

National Natural Science Foundation of China

Changjiang Scholars and Innovative Research Team in University

Science and Technology Program of Guangdong

Science and Technology Program of Guangzhou

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference58 articles.

1. The role of nutrition in the risk and burden of stroke: an update of the evidence;Hankey;Stroke,2017

2. Advances in stroke therapy;Jaffer;Drug Deliv. Translat. Res.,2011

3. Genetic understanding of stroke treatment: potential role for phosphodiesterase inhibitors;Munshi;Adv. Neurobiol.,2017

4. Regulation of CRE-dependent transcription by presenilins: prospects for therapy of Alzheimer's disease;Beglopoulos;Trends Pharmacol. Sci.,2006

5. Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model;Boomkamp;Br. J. Pharmacol.,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitofusin 2 Mediates the Protective Effect of NR6A1 Silencing Against Neuronal Injury in Experimental Stroke Models;Molecular Neurobiology;2024-09-11

2. PDE4D: A Multipurpose Pharmacological Target;International Journal of Molecular Sciences;2024-07-24

3. Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification;Journal of Ethnopharmacology;2024-07

4. Luteolin-7-O-β-d-Glucuronide Attenuated Cerebral Ischemia/Reperfusion Injury: Involvement of the Blood–Brain Barrier;Biomedicines;2024-06-19

5. Inhibition of phosphodiesterase 4 attenuates aquaporin 4 expression and astrocyte swelling following cerebral ischemia/reperfusion injury;Glia;2024-05-24